NEUPROGRAMMIERUNG VON KÖRPERZELLEN

European patent · EP3878949 · In force

Register entry

Publication number
EP3878949
Application number
EP21162420
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Apr 7, 2008
Published
Sep 15, 2021
Granted
Jun 4, 2025
Protection ends at the latest
Apr 6, 2028
Next annual fee due
Apr 30, 2026
IPC classes
C12N 5/074 (2010.01)
Priority
US 922121 P 07.04.2007
US 959341 P 12.07.2007
US 3606508 P 12.03.2008
Divided from
EP08742630
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Apr 16, 2026

    Change

    Published in Swissreg on 16.04.2026

  2. Jun 4, 2025

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 04.06.2025

Parties

Holder

Whitehead Institute for Biomedical Research

455 Main Street, Cambridge, MA 02142, US

Inventor

JAENISCH, Rudolph

Brookline, MA 02146, US

HANNA, Jacob

Boston, MA 02118, US

WERNIG, Marius

Cambridge, MA 021139, US

LENGNER, Christopher, J.

Wellesley, MA 12481, US

MEISSNER, Alexander

Cambridge, MA 02142, US

BRAMBRINK, Oliver, Tobias

Cambridge, MA 02138, US

WELSTEAD, G., Grant

Cambridge, MA 02139, US

FOREMAN, Ruth

Somerville, MA 02145, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.